Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center
Advertisement
Articles by Adil Daud, MD, UCSF Helen Diller Family Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Dr. Daud Discusses the Current Status of Immunotherapy in MelanomaPublished: August 28th 2017 | Updated:
Dr. Daud Discusses the Immunogenicity of MelanomaPublished: May 17th 2019 | Updated:
Dr. Daud on Interferon Gamma as a Biomarker in MelanomaPublished: November 8th 2019 | Updated:
Dr. Daud on Dabrafenib/Trametinib Vs Immunotherapy in MelanomaPublished: December 5th 2019 | Updated:
Dr. Daud on the Combinations of Immunotherapy for MelanomaPublished: July 6th 2017 | Updated:
Dr. Daud on Challenges Facing the Treatment Landscape for MelanomaPublished: October 19th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5